GlassScriptPhysician profile
Virginia Ransom
NPI 1386077246
$7,048.85
in general payments reported to CMS, 2019-2025
55 companies · $1,120 in 2025
The $1,120 reported for 2025 was more than what 86% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,075 · 2022: $1,816 · 2023: $1,582 · 2024: $1,456 · 2025: $1,120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,159.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,158.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $902.54 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $872.27 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $646.94 | 2021-2025 | Farxiga, Breztri, Airsupra |
| Lilly USA, LLC | $626.84 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Janssen Pharmaceuticals, INC | $365.40 | 2021-2025 | Spravato |
| Glaxosmithkline, LLC. | $334.13 | 2021-2025 | Shingrix, Trelegy Ellipta, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $297.51 | 2021-2025 | Jardiance |
| Biohaven Pharmaceutical Holding Company LTD. | $207.14 | 2022 | |
| Pfizer INC. | $191.82 | 2022-2025 | |
| Exact Sciences Corporation | $180.35 | 2023-2025 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $179.49 | 2021-2025 | |
| Corium, LLC | $178.89 | 2022-2023 | Azstarys |
| Amarin Pharma, INC. | $153.60 | 2022-2023 | |
| Idorsia Pharmaceuticals US INC | $138.37 | 2022-2024 | Quviviq |
| Biohaven Pharmaceuticals, INC. | $136.44 | 2021 |
Show all 55 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $130.76 | 2021-2024 | Belsomra, Steglatro, Gardasil |
| Amneal Pharmaceuticals LLC | $106.73 | 2021-2024 | Unithroid |
| Takeda Pharmaceuticals U.S.A., INC. | $104.52 | 2021-2022 | |
| Antares Pharma, INC. | $82.76 | 2021-2024 | Xyosted |
| Dexcom, INC. | $70.48 | 2024-2025 | Dexcom G6 Transmitter |
| Astellas Pharma US INC | $69.77 | 2025 | Veozah |
| Supernus Pharmaceuticals, INC. | $68.26 | 2022-2023 | Qelbree |
| Alexion Pharmaceuticals, INC. | $67.57 | 2021-2022 | |
| Esperion Therapeutics, INC. | $62.05 | 2021 | |
| Abbott Laboratories | $57.38 | 2021-2025 | Freestyle Libre 3 |
| Eisai INC. | $53.53 | 2024-2025 | |
| Amgen INC. | $51.16 | 2021-2024 | Krystexxa |
| Inari Medical, INC. | $47.50 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $44.20 | 2022-2023 | Cycloset |
| Itamar Medical INC | $40.83 | 2022-2023 | Watchpatone |
| Clarus Therapeutics INC. | $38.26 | 2021 | |
| Sanofi Pasteur INC. | $38.09 | 2023-2025 | |
| Dynavax Technologies Corporation | $37.25 | 2023-2025 | Heplisav-B |
| Lundbeck LLC | $36.07 | 2023-2025 | Vyepti, Rexulti |
| Medtronic, INC. | $34.14 | 2021 | |
| Tolmar, INC. | $33.49 | 2023 | |
| Coloplast Corp | $33.40 | 2021 | |
| Azurity Pharmaceuticals, INC. | $27.50 | 2023 | Edarbyclor |
| Axsome Therapeutics, INC. | $25.17 | 2024 | Auvelity |
| Sandoz INC. | $23.46 | 2024 | |
| Qol Medical, LLC | $23.05 | 2024 | Sucraid |
| Seqirus USA INC | $20.29 | 2025 | Fluad, Flucelvax |
| Otsuka America Pharmaceutical, INC. | $19.63 | 2022 | |
| Sanofi-Aventis U.S. LLC | $19.21 | 2023 | |
| Spr Therapeutics, INC | $18.05 | 2024 | Sprint Pns System |
| Recordati_rare_diseases_inc. | $17.95 | 2022 | |
| Eusa Pharma (US) LLC | $17.95 | 2022 | |
| Nestle Healthcare Nutrition INC. | $17.83 | 2023 | |
| Ibsa Pharma INC. | $16.29 | 2023 | Tirosint, Licart |
| Jazz Pharmaceuticals INC. | $15.42 | 2022 | |
| Kyowa Kirin, INC. | $15.18 | 2025 | |
| Ultragenyx Pharmaceutical INC. | $14.40 | 2022 | |
| Inspire Medical Systems, INC. | $13.44 | 2023 | Inspire |
| Novartis Pharmaceuticals Corporation | $12.22 | 2021 | |
| Ascensia Diabetes Care US INC. | $11.88 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Virginia Ransom listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.